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The splanchnic and systemic hemodynamics of 14 patients with refractory ascites were studied and were
compared to those of 15 patients with ascites responding to medical treatment. Among the 14 patients,
10 were grade B and 4 C, according to the Pugh classification. Of the 15 patients, 5 were Pugh B and 10
C. In patients with refractory ascites, free hepatic venous pressure was significantly higher and hepatic
venous pressure gradient was significantly lower than in patients with responsive ascites. Hepatic and
azygos blood flows were not significantly different between the two groups. Cardiac output was lower in
patients with refractory ascites (p < 0.05) than in those with responsive ascites. In patients with
refractory ascites, six months after peritoneovenous shunting, there was a significant reduction of
wedged and free hepatic venous pressures and azygos blood flow. Cardiac output increased by 20% (p
< 0.02). This study shows that hemodynamic alterations in patients with refractory ascites is the
consequence of increased intraabdominal pressure due to chronic ascites. Six months after peritoneove-
nous shunting splanchnic and systemic hemodynamics became similar to those observed in patients
without ascites.
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INTRODUCTION
In patients with cirrhosis, splanchnic and systemic hemodynamics are altered1-4.
These changes are related to both the development of portal-systemic collateral
circulation and the severity of liver failure6. The hemodynamics of patients with
cirrhosis and refractory ascites has been less well documented7. Although the
immediate consequences of peritoneovenous shunting on systemic hemodynamics
have been well demonstrated8’9, its long term influence on splanchnic and systemic
hemodynamics is poorly understood1. The purpose of this work was to study the
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splanchnic and systemic hemodynamics before and 6 months after peritoneovenous
shunting in a series of 14 consecutive patients with cirrhosis and refractory ascites in
order to determine first, if preoperative measurements were similar to those of
patients with ascites responding to medical treatment and second, the late hemody-
namic consequences of shunting.
PATIENTS AND METHODS
Patients
Twenty-nine adult patients admitted for ascites were studied. Transvenous liver
biopsy showed alcoholic cirrhosis in all patients. Among these patients, 15 res-
ponded to the medical treatment and 14 had refractory ascites. Four of the former
patients had histological lesions of acute alcoholic hepatitis. Laboratory values at
the time of the investigation are indicated in Table 1. The severity of cirrhosis was
estimated according to Pugh’s classification11. In patients with refractory ascites 10
were grade B and 4 C. In patients with responsive ascites, 5 were grade B and 10 C
(p < 0.01). The medical treatment included at least bed rest, suppression of
alcoholic intake, salt restricted diet (< 20 mmol/day), water restriction (< 1
1/day), spironolactone (at least 600 mg/day) and/or Frusemide (at least 200 mg/
day). Ascites were considered refractory when medical treatment failed to control
ascites and/or induced a decrease of natremia below 125 mmol/1 and/or an increase
in creatinine blood level above 100 #mol/l. In patients with refractory ascites,
ascites had been present for 3 to 13 months (mean: 7.2 + 3.2 months). In the 15
patients with ascites responding to the medical treatment, ascites had been present
for 15 days to 2 months (mean: 0.9 + 0.7 months).
Peritoneovenous shunting was performed using the LeVeen shunt as previously
described12. The venous catheter was introduced through the right internal jugular
vein. The tip of the venous tubing was placed at the junction of the superior vena
cava and of the right atrium under X-ray control. The functioning of the shunt was
always tested by injecting methylen blue in the peritoneal cavity at the end of the
operation and checking its appearance in the cervical portion of the venous tubing.
Postoperative treatment included chest physiotherapy and abdominal binding. One
dose of fruosemide (40 mg) was administered in the operating room, after the
insertion of the shunt and was then discontinued.
Systemic and splanchnic hemodynamic investigations were performed in all
patients. In the 14 patients with refractory ascites, the hemodynamic measurements
were repeated 6 months after successful peritoneovenous shunting. At the time of
the first hemodynamic study, ascites were massive in all patients.
All patients gave oral informed consent in the presence of a witness to the
investigations described below.
Hemodynamic Studies
The hemodynamic studies were performed in patients positioned supine after an
overnight fast. Under local anesthesia, a vessel dilator with a polypropylene sheath
(Desilets, Vygon, Ecouen, France) was positioned in the lumen of the right jugular
vein in order to introduce successively different catheters. The gradient between261
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wedged and free hepatic venous pressures (hepatic venous pressure gradient) was
measured with a 7F catheter (cordis Sa, Miami, FL) introduced into a right hepatic
vein under fluoroscopy; the wedged position of the catheter was checked as
previously described with contrast medium13. The zero reference level was arbitrar-
ily positioned at the midaxillary line level. Hepatic blood flow was estimated by the
indocyanine green continuous infusion methodTM. Hepatic blood flow was calcu-
lated only in patients in whom hepatic indocyanine green extraction was more than
10%. Cardiac output was measured by the thermodilation method with a
Swan-Ganz catheter; this catheter was used for measurements of right atrial
pressure, mean pulmonary artery pressure and pulmonary wedged pressure.
Azygos blood flow was measured with a continuous thermodilution catheter
(Webster Laboratories, Altadena, CA) introduced into the arch of the azygos vein;
the details have been previously described15. During this procedure, arterial
pressure was measured by an external monitoring sphygmomanometer (Dinamap,
Critikon Inc. Tampa, FL), and heart rate was determined by continuous ECG
monitoring. Mean arterial pressure (MAP) was electronically integrated. Systemic
vascular resistance (SVR) was calculated according to the following formula:
SVR (MAP right atrial pressure) 80/cardiac output.
No complication occurred in any patients during the hemodynamic investigation.
Statistical Analysis
The results are expressed as mean + SD. The Student’s t test for paired data was
used for statistical comparisons.
RESULTS
Comparison of the Hemodynamic Values Between Responsive and Refractory
Ascites (Table 2)
Hepatic venous pressure gradient was lower in patients with refractory ascites than
in those with responsive ascites. This resulted from a high free hepatic venous
pressure in patients with refractory ascites. Cardiac output in the refractory ascitic
patients was significantly lower than in the responsive group. Hepatic and azygos
blood flows were not significantly different between the two groups.
Comparison of the Hemodynamic Values before and 6 Months after
Peritoneovenous Shunting in Patients with Refractory Ascites (Table 2)
Surgical peritoneovenous shunting was effective in the management of ascites in all
patients and patency of the shunt was assessed by shuntography as previously
described16. Shuntography was performed by transcutanoous puncture of the
venous catheter with a 21-gauge needle. Ten milliliters of contrast medium were
slowly injected, and the progression was supervised on a television screen. In a
normally functioning shunt, contrast medium was washed out in less than 15
seconds. Six months after peritoneovenous shunting, all patients were in good263
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condition without detectable ascites at ultrasonograpahic examination. None had
diuretic requirement. Hemodynamic investigations demonstrated a significant
decrease in both wedged and free hepatic venous pressure. Hepatic venous
pressure gradient was not different from preoperative values. Azygos blood flow
significantly decreased by 45% after peritoneovenous shunting. Hepatic blood flow
increased by 35%; this was not however significant. Cardiac output significantly
increased in all patients after shunting.
DISCUSSION
The present study suggest that hemodynamic alterations in patients with refractory
ascites result from an increase in abdominal pressure and that peritoneovenous
shunting improves both splanchnic and systemic hemodynamics by relieving abdo-
minal pressure and enhancing venous return.
It has been postulated that, in patients with cirrhosis, the hyperkinetic syndrome
was related to the degree of portosystemic shunting and to the severity of liver
disease5’6. Although refractory ascites is usually considered a feature of severe liver
disease, patients with refractory ascites in this study did not have a hyperkinetic
systemic circulation. Cardiac output and hepatic venous pressure gradient were
lower in patients with refractory ascites than in those with responsive ascites. The
degree of liver failure and abdominal pressure could account for these differences.
Liver failure was more severe in patients with responsive ascites than in those with
refractory ascites. On the other hand, in patients with refractory ascites, the ascites
was more prolonged and more compressive as assessed by the high free hepatic
venous pressure than in the patients with responsive ascites. It had been postuled
that ascites may also have a negative influence on cardiac function in patients with
cirrhosis17’18. This is based on clinical and experimental observations. In patients
with cirrhosis, cardiac output increased during paracentesis together with a
decrease in inferior vena cava and free hepatic venous pressures7-2. A decrease in
intraabdominal pressure has been proposed as the cause of these hemodynamic
alterations
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This change, however, was transient. Moreover, it has been demonstrated in the
dog that increasing abdominal pressure, by infusing fluid into the abdomen,
produced an increase in inferior vena cava pressure and a decrease in cardiac
output2’22’9-3. These previous observations support the concept that chronic tense
refractory ascites increases intraabdominal pressure and decreases cardiac output
and venous return. Thickness of the retroperitoneal space observed in patients with
prolonged ascites, might further increase the pressure on the inferior vena cava. In
addition, intravascular fluid depletion induced by repeated diuretic treatment may
contribute to the decrease in cardiac output24.
Short-term effects of peritoneovenous shunting were an increase in plasma
volume and a dramatic increase in cardiopulmonary pressures and cardiac
outputa’9. It probably accounted for the beneficial effect on peripheral flow and
improvement in renal functiona. It has been demonstrated that these hemodynamic
changes were of short duration and that hemodynamic values returned to preopera-
tive measurements within 2 weeks of the operations. Long-term effects of perito-
neovenous shunting on systemic and portal hemodynamics have not been well
documented. Greig et al. 1 observed no significant increase in cardiac output in aHEMODYNAMICS IN REFRACTORY ASCITES 265
small series of patients studied at different postoperative intervals (1 to 15 months).
They, however, found a persistent decrease in wedged hepatic venous pressure8’1.
In the present study, all patients have been investigated on the sixth postoperative
month, and no death or shunt obstruction occurred during this period. The two
major long-term consequences of shunting were a marked increase in cardiac
output and a decrease in wedged hepatic venous pressure. These results are
consistent with a reduction of abdominal pressure and an increase in cardiac venous
return. Following peritoneovenous shunting, the reduction of abdominal pressure
is prolonged, and permanent reinfusion of the ascitic fluid prevents hypovolemia.
In contrast, immediately after paracentesis, the increase in cardiac output is
transient. The return to initial values could be due to either a reaccumulation of
ascites, hypovolemia, or both21.
It has recently been postulated that peritoneovenous shunting may produce a
transient increase in portal pressure and then favour esophageal variceal
bleeding9’25-28. The long-term measurements in this series of patients showed, in
contrast, that wedged hepatic venous pressure significantly decreased after perito-
neovenous shunt. This might be associated with a decrease in hepatic vascular
resistance since total hepatic blood flow increased by 35%. Although the latter
value was not significant because of the wide range of variations, it could indicate a
better liver perfusion. The enhancement of liver perfusion could explain the
improvement of liver biochemical tests recently observed in patients after perito-
neovenous shunt29. Lastly azygos blood flow, also a reflection of superior portaca-
val collateral circulation, significantly decreased 6 months after peritoneovenous
shunting. This reduction is in agreement with both the decrease in wedged hepatic
venous pressure and the increase in hepatic blood flow. The decrease in wedged
hepatic venous pressure and in azygos blood flow observed 6 months after
peritoneovenous shunting, support the hypothesis that the risk of esophageal
variceal bleeding is not augmented.
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INVITED COMMENTARY
The clinical problems of tense ascites (pain, respiratory distress, immobility,
cosmetic deformity, etc.) have been known for centuries. In 1975, Guazzi and
co-workers drew attention to the potential harmful effect of ascitic fluid on
systemic hemodynamics. The short term effects of peritoneovenous (PV) shunting
on hemodynamics and neuro-humoral regulatory systems (increased cardiac out-
put, decreased portal pressure, suppression of the renin angiotensin aldosterone
system and the sympathetic nervous system, increased plasma atrial natriuretic
factor) are now well established2-. In contrast, we know less of the long term
effects6. This is in part due to the fact that most patients with decompensated
cirrhosis and refractory ascites are poor survivors, and a number of complications,
including shunt occlusion, are common after insertion of a PV shunt5. In the
present study by Vons and co-workers all patients survived and the shunts
remained open for at east six months. This provides an outstanding opportunity for
long-term study of pathophysiology. The main conclusion is that six months after
PV shunting splanchnic- and systemic hemodynamics became similar to those
values observed in other patients without ascites. Azygos blood flow, wedged and
free hepatic venous pressures decreased, and cardiac output increased significantly.
It is important to notice that the azygos venous blood flow decreased in spite of an
unchanged hepatic venous pressure gradient. This may be due to a greater
influence of the absolute pressure level of the splanchnic venous bed (wedged
hepatic vein pressure) than of the hepatic venous pressure gradient. This may
simply indicate that the absolute pressure is close to the hydrostatic pressure drop
from the esophageal varices to the right atrium. The presence of ascitic fluid will
due to its hydrostatic effect increase that pressure7. Consequently, amelioration of
ascites and thereby decrease of the wedged hepatic vein pressure may reduce the
risk of esophageal bleeding independently of any change in the hepatic venous
pressure gradient8.
It is important to stress that the principles of PV shunting are 1 abdominal
decompression in addition to 2 central blood volume expansion2-5’9. Previous
studies applying plasma volume expansion alone1 or abdominal decompression
alone
11 have not provided good results. The mechanisms by which the combined
effect of abdominal decompression and blood volume expansion exert their effects
are not fully understood. In this context, it should be recalled that decompression
of the renal veins may improve kidney function12’13. It should also be recognized
that in addition to a long term effect of a well-functioning PV shunt, spontaneous
improvement of cirrhotic patients including reduction of wedged hepatic vein
pressure may take place14. Finally, decreased systemic vascular resistance plays a
centrol role in genesis and perpetuation of hepatic ascites15. In the present study
arterial blood pressure and systemic vascular resistance increased somewhat268 C. VONS ET AL.
although not significantly. PV shunting might be combined with vasopressor drugs
in order to normalize systemic hemodynamics and thereby renal perfusion
pressure16.
The present investigation shows that several patients with refractory ascites and
systemic hemodynamic derangement may have a relatively well preserved liver
function. This is stressed by the fact that the patients in the refractory group had a
lower Pugh score than in the responsive group (p 0.1, Fisher’s exact test). A
larger number of patients than previously recognised may suffer from "systemic
hemodynamic complications" at a stage of their disease where the hepatocellular
function is relatively intact.
Controlled trials of patients with refractory ascites, involving randomization
either to PV shunting or to intensive diuretic treatment have not documented any
superior long term effect of the PV shunt with respect to survival 17,18. Still the PV
shunt offers a rational therapy from a pathophysiological point of view. Technical
improvements including reduction of the rate of complications of PV shunting are
awaited.
Jens H. Henriksen
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